OVERVIEW
Paroxysmal supraventricular tachycardia (PSVT) – an old problem or a new opportunity? PSVT is a common cardiac arrhythmia characterized by spontaneous episodes of ventricular contractions exceeding rates of 100 beats per minute. Due to the sporadic nature of this disease and fluctuation in frequency and severity of symptoms, PSVT can be difficult to diagnose, and it significantly affects patient quality of life. This life-altering disease affects 1 in 300 patients, however, prevalence as well as economic burden are increasing exponentially. In this symposium, experts will discuss hot topics on PSVT including clinical burden of disease, guideline recommendations, and current as well as emerging treatment strategies for PSVT.
GOAL STATEMENT
The goal of this activity is for learners to be better able to identify the clinical and economic burden of paroxysmal supraventricular tachycardia (PSVT), evaluate current and emerging PSVT treatment approaches and discuss implications for improved patient outcomes.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Effect of PSVT on patient quality of life (QoL) and outcomes[ITEM]Guideline-recommended PSVT treatment approaches[ITEM]Mechanisms of emerging pharmacologic treatment strategies for PSVT[ITEM]Latest clinical data for the use of novel pharmacologic treatment strategies for PSVT[/LIST]Have greater competence related to[LIST][ITEM]Identifying patients who may benefit from emerging pharmacologic treatment strategies for PSVT[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Discern the value of novel therapeutic approaches to treat patients with PSVT[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Westin Philadelphia
Georgian Ballroom
99 South 17th Street at Liberty Place
Philadelphia, Pennsylvania, 19103
United States
This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.
Supported by an independent educational grant from [bold]Milestone Pharmaceuticals[/bold].